Denna sida på svenska
Loading profile information...

About me

I am a Professor in Cancer Epidemiology and since 2011 Deputy chair at the Department of Medical Epidemiology and Biostatistics. My research focuses on the etiology of breast cancer in a very broad sense.

Education

  • PhD in Molecular Epidemiology - Karolinska Institutet, Stockholm, Sweden
  • MSci in Nuclear Engineering - Faculty of Nuclear Science and Physical Engineering, Czech Technical University, Prague, Czech Republic

Research description

Main research focus:  Breast cancer prognosis

There are both host (patient) and tumor characteristics that define breast cancer prognosis, as well as treatment response and complications. The central concept of my research agenda is to acquire a comprehensive picture of the determinants of prognosis in breast cancer patients using high quality epidemiological studies, molecular data and state-of-the-art analyses to combine information on patient and tumor determinants. The main aims of my current research are the following:

  • To determine genetic variants associated with prognosis of breast cancer (inherited alterations)
  • To identify novel breast- tumor specific markers for disease progression (somatic alterations)
  • To study the long-term breast cancer prognosis as well as the panorama of diseases in breast cancer survivors.

Other research interests

  • Mammographic screening and interval breast cancer
  • Breast cancer risk and prevention
  • Better understanding of mammographic density and implementation for clinical use
  • Genetic studies on (any) cancer
  • Twin studies on (any) cancer
  • Family studies on (any) cancer including development of statistical methods
  • Epidemiological Methods

Research projects

Current supervision of PhD students

Current post docs

Current research grants (as PI)
My research work is supported by Swedish Research Council (Vetenskapsrådet), FORTE,  Cancerföreningen, Swedish Cancer Society (Cancerfonden), Stockholm County Council (SLL/ALF).

Selected articles

Holm J, Li J, Darabi H, Eklund M, Eriksson M, Humphreys K, Hall P and Czene K. Associations of breast cancer risk prediction tools with tumor characteristics and metastasis. Journal of Clinical Oncology. 2015. [epub ahead of print]

Predictors of Discontinuation of Adjuvant Hormone Therapy in Patients With Breast Cancer.
He W, Fang F, Varnum C, Eriksson M, Hall P, Czene K
J. Clin. Oncol. 2015 Jul;33(20):2262-9

Risk factors and tumor characteristics of interval cancers by mammographic density.
Holm J, Humphreys K, Li J, Ploner A, Cheddad A, Eriksson M, et al
J. Clin. Oncol. 2015 Mar;33(9):1030-7

Volumetric mammographic density: heritability and association with breast cancer susceptibility loci.
Brand J, Humphreys K, Thompson D, Li J, Eriksson M, Hall P, et al
J. Natl. Cancer Inst. 2014 Dec;106(12):

2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy.
Li J, Lindström L, Foo J, Rafiq S, Schmidt M, Pharoah P, et al
Nat Commun 2014 Jun;5():4051

Academic honours, awards and prizes

In 2007 I recieved the "Young Investigator Award" a 6-year full research position from the Swedish Cancer Society.

Publications

A comprehensive tool for measuring mammographic density changes over time
Eriksson M, Li J, Leifland K, Czene K, Hall P
Breast cancer research and treatment 2018;169(2):371-379

Affinity proteomic profiling of plasma for proteins associated to area-based mammographic breast density
Byström S, Eklund M, Hong Mg, Fredolini C, Eriksson M, Czene K, et al
Breast cancer research : BCR 2018;20(1):14-

Association of reproductive history with breast tissue characteristics and receptor status in the normal breast
Gabrielson M, Chiesa F, Behmer C, Rönnow K, Czene K, Hall P
Breast cancer research and treatment 2018;170(3):487-497

Feasibility of reusing time-matched controls in an overlapping cohort
Delcoigne B, Hagenbuch N, Schelin Me, Salim A, Lindström Ls, Bergh J, et al
Statistical methods in medical research 2018;27(6):1818-1829

Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses
Painter Jn, O'mara Ta, Morris Ap, Cheng Tht, Gorman M, Martin L, et al
Cancer medicine 2018;7(5):1978-1987

Inherited factors contribute to an inverse association between preeclampsia and breast cancer
Yang H, He W, Eriksson M, Li J, Holowko N, Chiesa F, et al
Breast cancer research : BCR 2018;20(1):6-

Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer
Sto Trialists Group, Lindström Ls, Yau C, Czene K, Thompson Ck, Hoadley Ka, et al
Journal of the National Cancer Institute 2018;110(7):726-733

Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium
Rudolph A, Song M, Brook Mn, Milne Rl, Mavaddat N, Michailidou K, et al
International journal of epidemiology 2018;47(2):526-536

The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity
Kconfab/aocs Investigators, Colombo M, Lòpez-perolio I, Meeks Hd, Caleca L, Parsons Mt, et al
Human mutation 2018;39(5):729-741

Time from breast cancer diagnosis to therapeutic surgery and breast cancer prognosis: A population-based cohort study
Eriksson L, Bergh J, Humphreys K, Wärnberg F, Törnberg S, Czene K
International journal of cancer 2018;143(5):1093-1104

A clinical model for identifying the short-term risk of breast cancer
Eriksson M, Czene K, Pawitan Y, Leifland K, Darabi H, Hall P
Breast cancer research : BCR 2017;19(1):29-

Assessment of Breast Cancer Risk Factors Reveals Subtype Heterogeneity
Holm J, Eriksson L, Ploner A, Eriksson M, Rantalainen M, Li J, et al
Cancer research 2017;77(13):3708-3717

Association analysis identifies 65 new breast cancer risk loci
Abctb Investigators, Nbcs Collaborators, Confab/aocs Investigators, Michailidou K, Lindström S, Dennis J, et al
Nature 2017;551(7678):92-94

Associations between childhood body size and seventeen adverse outcomes: analysis of 65,057 European women
Li J, Eriksson M, He W, Hall P, Czene K
Scientific reports 2017;7(1):16917-

Body mass index and breast cancer survival: a Mendelian randomization analysis
Kconfab/aocs Investigators, Guo Q, Burgess S, Turman C, Bolla Mk, Wang Q, et al
International journal of epidemiology 2017;46(6):1814-1822

BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer
For Nbcs Collaborators, For Kconfab/aocs Investigators, Shimelis H, Mesman Rls, Von Nicolai C, Ehlen A, et al
Cancer research 2017;77(11):2789-2799

Breaking the matching in nested case-control data offered several advantages for risk estimation
Delcoigne B, Colzani E, Prochazka M, Gagliardi G, Hall P, Abrahamowicz M, et al
Journal of clinical epidemiology 2017;82():79-86

Breast Tissue Organisation and its Association with Breast Cancer Risk
Ali Ma, Czene K, Eriksson L, Hall P, Humphreys K
Breast cancer research : BCR 2017;19(1):103-

Cause-specific mortality in women with breast cancer in situ
He W, Sofie Lindström L, Hall P, Czene K
International journal of cancer 2017;140(11):2414-2421

Cohort Profile: The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA)
Gabrielson M, Eriksson M, Hammarström M, Borgquist S, Leifland K, Czene K, et al
International journal of epidemiology 2017;46(6):1740-1741g

Common shared genetic variation behind decreased risk of breast cancer in celiac disease
Ugalde-morales E, Li J, Humphreys K, Ludvigsson Jf, Yang H, Hall P, et al
Scientific reports 2017;7(1):5942-

Differences in mammographic density between Asian and Caucasian populations: a comparative analysis
Rajaram N, Mariapun S, Eriksson M, Tapia J, Kwan Py, Ho Wk, et al
Breast cancer research and treatment 2017;161(2):353-362

Differences in survival for patients with familial and sporadic cancer
Lee M, Reilly M, Lindström Ls, Czene K
International journal of cancer 2017;140(3):581-590

E-Science technologies in a workflow for personalized medicine using cancer screening as a case study
Spjuth O, Karlsson A, Clements M, Humphreys K, Ivansson E, Dowling J, et al
Journal of the American Medical Informatics Association : JAMIA 2017;24(5):950-957

Familial Risk and Heritability of Colorectal Cancer in the Nordic Twin Study of Cancer
Graff Re, Möller S, Passarelli Mn, Witte Js, Skytthe A, Christensen K, et al
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2017;15(8):1256-1264

Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium
Barrdahl M, Rudolph A, Hopper Jl, Southey Mc, Broeks A, Fasching Pa, et al
International journal of cancer 2017;141(9):1830-1840

Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer Cohorts
Lundberg A, Lindström Ls, Harrell Jc, Falato C, Carlson Jw, Wright Pk, et al
Clinical cancer research : an official journal of the American Association for Cancer Research 2017;23(24):7512-7520

Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk
Kconfab/aocs Investigators, Interact Consortium, Lifelines Cohort Study, Endometrial Cancer Association Consortium, Ovarian Cancer Association Consortium, Practical Consortium, et al
Nature genetics 2017;49(6):834-841

Longitudinal fluctuation in mammographic percent density differentiates between interval and screen-detected breast cancer
Strand F, Humphreys K, Eriksson M, Li J, Andersson Tm, Törnberg S, et al
International journal of cancer 2017;140(1):34-40

Lung cancer, genetic predisposition and smoking: the Nordic Twin Study of Cancer
Nordic Twin Study Of Cancer (nortwincan) Collaboration, Hjelmborg J, Korhonen T, Holst K, Skytthe A, Pukkala E, et al
Thorax 2017;72(11):1021-1027

Mammographic Density Reduction as a Prognostic Marker for Postmenopausal Breast Cancer: Results Using a Joint Longitudinal-Survival Modeling Approach
Andersson Tml, Crowther Mj, Czene K, Hall P, Humphreys K
AMERICAN JOURNAL OF EPIDEMIOLOGY 2017;186(9):1065-1073

Molecular Differences between Screen-Detected and Interval Breast Cancers Are Largely Explained by PAM50 Subtypes
Li J, Ivansson E, Klevebring D, Tobin Np, Lindström Ls, Holm J, et al
Clinical cancer research : an official journal of the American Association for Cancer Research 2017;23(10):2584-2592

PAM50 Provides Prognostic Information When Applied to the Lymph Node Metastases of Advanced Breast Cancer Patients
Tex Trialists Group, Tobin Np, Lundberg A, Lindström Ls, Harrell Jc, Foukakis T, et al
Clinical cancer research : an official journal of the American Association for Cancer Research 2017;23(23):7225-7231

Patterns of acute inflammatory symptoms prior to cancer diagnosis
Setiawan A, Yin L, Auer G, Czene K, Smedby Ke, Pawitan Y
Scientific reports 2017;7(1):67-

PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1
Nbcs Collaborators, Kconfab/aocs Investigators, Jiao X, Aravidis C, Marikkannu R, Rantala J, et al
Oncotarget 2017;8(61):102769-102782

Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study
Kconfab, Brouckaert O, Rudolph A, Laenen A, Keeman R, Bolla Mk, et al
Breast cancer research : BCR 2017;19(1):119-

Risk and predictors of psoriasis in patients with breast cancer: a Swedish population-based cohort study
Yang H, Brand Js, Li J, Ludvigsson Jf, Ugalde-morales E, Chiesa F, et al
BMC medicine 2017;15(1):154-

Site-specific familial risk and survival of familial and sporadic head and neck cancer
Renkonen S, Lee M, Mäkitie A, Lindström Ls, Czene K
International journal of cancer 2017;141(3):497-502

Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study
Brand Js, Hedayati E, Bhoo-pathy N, Bergh J, Hall P, Humphreys K, et al
Cancer 2017;123(3):468-475

Time-dependent risk of depression, anxiety, and stress-related disorders in patients with invasive and in situ breast cancer
Yang H, Brand Js, Fang F, Chiesa F, Johansson Al, Hall P, et al
International journal of cancer 2017;140(4):841-852

TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer
Kconfab/aocs Investigators, Fagerholm R, Khan S, Schmidt Mk, García-closas M, Heikkilä P, et al
Oncotarget 2017;8(11):18381-18398

Treatment Restarting After Discontinuation of Adjuvant Hormone Therapy in Breast Cancer Patients
He W, Smedby Ke, Fang F, Olsson H, Margolin S, Hall P, et al
Journal of the National Cancer Institute 2017;109(10):-

Age- and Tumor Subtype Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers
Schmidt Mk, Hogervorst F, Van Hien R, Cornelissen S, Broeks A, Adank Ma, et al
JOURNAL OF CLINICAL ONCOLOGY 2016;34(23):2750-60

Amount of stroma is associated with mammographic density and stromal expression of oestrogen receptor in normal breast tissues
Gabrielson M, Chiesa F, Paulsson J, Strell C, Behmer C, Rönnow K, et al
Breast cancer research and treatment 2016;158(2):253-61

An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression
Genica Network, Australian Ovarian Cancer Study Group, Kconfab Investigators, Wyszynski A, Hong Cc, Lam K, et al
Human molecular genetics 2016;25(17):3863-3876

Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21
Kconfab/aocs Investigators, Nbcs Collaborators, Hamdi Y, Soucy P, Adoue V, Michailidou K, et al
Oncotarget 2016;7(49):80140-80163

Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry
Zhao Z, Wen W, Michailidou K, Bolla Mk, Wang Q, Zhang B, et al
Cancer causes & control : CCC 2016;27(5):679-93

Association of infertility and fertility treatment with mammographic density in a large screening-based cohort of women: a cross-sectional study
Lundberg Fe, Johansson Al, Rodriguez-wallberg K, Brand Js, Czene K, Hall P, et al
Breast cancer research : BCR 2016;18(1):36-

Associations of Breast Cancer Risk Prediction Tools With Tumor Characteristics and Metastasis
Holm J, Li J, Darabi H, Eklund M, Eriksson M, Humphreys K, et al
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016;34(3):251-8

Birth rates among male cancer survivors and mortality rates among their offspring: a population-based study from Sweden
Tang Sw, Liu J, Juay L, Czene K, Miao H, Salim A, et al
BMC cancer 2016;16():196-

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
Prostate Canc Assoc Grp, Ocgn, Gemo Study Collaborators, Hebon, Australia Ovarian Canc Study Grp, Kconfab Investigators, et al
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 2016;108(2):-

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170
Embrace, Hebon, Gemo Study Collaborators, Kconfab Investigators, Dunning Am, Michailidou K, et al
Nature genetics 2016;48(4):374-86

Chemotherapy, Genetic Susceptibility, and Risk of Venous Thromboembolism in Breast Cancer Patients
Brand Js, Hedayati E, Humphreys K, Ludvigsson Jf, Johansson Al, Bergh J, et al
Clinical cancer research : an official journal of the American Association for Cancer Research 2016;22(21):5249-5255

Clinical Diagnosis of Mental Disorders Immediately Before and After Cancer Diagnosis: A Nationwide Matched Cohort Study in Sweden
Lu D, Andersson Tm, Fall K, Hultman Cm, Czene K, Valdimarsdóttir U, et al
JAMA oncology 2016;2(9):1188-96

Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms
De La Hoya M, Soukarieh O, López-perolio I, Vega A, Walker Lc, Van Ierland Y, et al
Human molecular genetics 2016;25(11):2256-2268

Common diseases as determinants of menopausal age
Li J, Eriksson M, Czene K, Hall P, Rodriguez-wallberg Ka
Human reproduction (Oxford, England) 2016;31(12):2856-2864

Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations
African American Breast Cancer Consortium (aabc) And African Ancestry Prostate Cancer Consortium (aapc), Colorectal Transdisciplinary (corect) Study, Hereditary Breast And Ovarian Cancer Research Group Netherlands (hebon), Practical Consortium, Ovarian Cancer Association Consortium (ocac), Fehringer G, et al
Cancer research 2016;76(17):5103-14

CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer
Aocs Group, Australian National Endometrial Cancer Study Group (anecs), National Study Of Endometrial Cancer Genetics Group (nsecg), For Rendocas, Thompson Dj, O'mara Ta, et al
Endocrine-related cancer 2016;23(2):77-91

Determining breast cancer histological grade from RNA-sequencing data
Wang M, Klevebring D, Lindberg J, Czene K, Grönberg H, Rantalainen M
Breast cancer research : BCR 2016;18(1):48-

Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation
Nbcs Collaborators, Kconfab/aocs Investigators, Ghoussaini M, French Jd, Michailidou K, Nord S, et al
American journal of human genetics 2016;99(4):903-911

Familial Risk and Heritability of Cancer Among Twins in Nordic Countries
Nordic Twin Study Of Cancer (nortwincan) Collaboration, Mucci La, Hjelmborg Jb, Harris Jr, Czene K, Havelick Dj, et al
JAMA 2016;315(1):68-76

Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus
Kconfab/aocs Investigators, Horne Hn, Chung Cc, Zhang H, Yu K, Prokunina-olsson L, et al
PloS one 2016;11(8):e0160316-

Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer
Mervi Grip, Kconfab Investigators, Shi J, Zhang Y, Zheng W, Michailidou K, et al
International journal of cancer 2016;139(6):1303-1317

Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs)
Darabi H, Beesley J, Droit A, Kar S, Nord S, Moradi Marjaneh M, et al
Scientific reports 2016;6():32512-

Five endometrial cancer risk loci identified through genome-wide association analysis
Rendocas, National Study Of Endometrial Cancer Genetics Group (nsecg), Aocs Group, Australian National Endometrial Cancer Study Group (anecs), Cheng Th, Thompson Dj, et al
Nature genetics 2016;48(6):667-674

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
Gemo Study Collaborators, Embrace, Hereditary Breast And Ovarian Cancer Research Group Netherlands (hebon), Kconfab Investigators, Australian Ovarian Cancer Study Group, Lawrenson K, et al
Nature communications 2016;7():12675-

Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent
Guo Y, Warren Andersen S, Shu Xo, Michailidou K, Bolla Mk, Wang Q, et al
PLoS medicine 2016;13(8):e1002105-

Genetic predisposition to ductal carcinoma in situ of the breast
Petridis C, Brook Mn, Shah V, Kohut K, Gorman P, Caneppele M, et al
Breast cancer research : BCR 2016;18(1):22-

Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer
Australian National Endometrial Cancer Study Group (anecs), National Study Of Endometrial Cancer Genetics Group (nsecg), For Rendocas, Aocs Group, Painter Jn, O'mara Ta, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2016;25(11):1503-1510

Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium
Kconfab Investigators, Australian Ovarian Study Group, Lei J, Rudolph A, Moysich Kb, Behrens S, et al
Human genetics 2016;135(1):137-54

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
Aocs Study Group & Australian Cancer Study (ovarian Cancer), Abctb Investigators, Nbcs Investigators, Kconfab Investigators, Genica Network, Practical Consortium, et al
Cancer discovery 2016;6(9):1052-67

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
Couch Fj, Kuchenbaecker Kb, Michailidou K, Mendoza-fandino Ga, Nord S, Lilyquist J, et al
Nature communications 2016;7():11375-

Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus
Embrace, Kconfab, Aocs Investigators, Hebon, Behalf Of Gemo Study Collaborators, Zeng C, et al
Breast cancer research : BCR 2016;18(1):64-

Infection-related hospitalizations in breast cancer patients: Risk and impact on prognosis
Brand Js, Colzani E, Johansson Alv, Giesecke J, Clements M, Bergh J, et al
The Journal of infection 2016;72(6):650-658

No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing
Australian Ovarian Cancer Study Group, Lifepool Investigators, Kconfab Investigators, Nbcs Investigators, Easton Df, Lesueur F, et al
Journal of medical genetics 2016;53(5):298-309

Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study
Strand F, Humphreys K, Cheddad A, Törnberg S, Azavedo E, Shepherd J, et al
Breast cancer research : BCR 2016;18(1):100-

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
Australian Ovarian Cancer Study Group, Southey Mc, Goldgar De, Winqvist R, Pylkäs K, Couch F, et al
Journal of medical genetics 2016;53(12):800-811

Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium
Muranen Ta, Blomqvist C, Dörk T, Jakubowska A, Heikkilä P, Fagerholm R, et al
Breast cancer research : BCR 2016;18(1):98-

Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancer
Koitsalu M, Sprangers Ma, Eklund M, Czene K, Hall P, Grönberg H, et al
Acta oncologica (Stockholm, Sweden) 2016;55(1):45-51

RAD51B in Familial Breast Cancer
Kconfab/aocs Investigators, Pelttari Lm, Khan S, Vuorela M, Kiiski Ji, Vilske S, et al
PloS one 2016;11(5):e0153788-

Risk of hospitalisation and death due to bone fractures after breast cancer: a registry-based cohort study
Colzani E, Clements M, Johansson Al, Liljegren A, He W, Brand J, et al
British journal of cancer 2016;115(11):1400-1407

rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk
Nbcs Collaborators, Liu J, Lončar I, Collée Jm, Bolla Mk, Dennis J, et al
Scientific reports 2016;6():36874-

Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers
Rantalainen M, Klevebring D, Lindberg J, Ivansson E, Rosin G, Kis L, et al
Scientific reports 2016;6():38037-

The Heritability of Breast Cancer among Women in the Nordic Twin Study of Cancer
Möller S, Mucci La, Harris Jr, Scheike T, Holst K, Halekoh U, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2016;25(1):145-50

The HLA-DQβ1 insertion is a strong achalasia risk factor and displays a geospatial north-south gradient among Europeans
Becker J, Haas Sl, Mokrowiecka A, Wasielica-berger J, Ateeb Z, Bister J, et al
European journal of human genetics : EJHG 2016;24(8):1228-31

The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden
Sackey H, Hui M, Czene K, Verkooijen H, Edgren G, Frisell J, et al
Breast cancer research : BCR 2016;18(1):105-

Worse quality of life in young and recently diagnosed breast cancer survivors compared with female survivors of other cancers: A cross-sectional study
Li J, Humphreys K, Eriksson M, Dar H, Brandberg Y, Hall P, et al
International journal of cancer 2016;139(11):2415-25

A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density
Rudolph A, Fasching Pa, Behrens S, Eilber U, Bolla Mk, Wang Q, et al
Breast cancer research : BCR 2015;17():110-

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy
Kconfab Invest, Lei J, Rudolph A, Moysich Kb, Rafiq S, Behrens S, et al
BREAST CANCER RESEARCH 2015;:18-

Background risk of breast cancer and the association between physical activity and mammographic density
Trinh T, Eriksson M, Darabi H, Bonn Se, Brand Js, Cuzick J, et al
BREAST CANCER RESEARCH 2015;:50-

Background risk of breast cancer influences the association between alcohol consumption and mammographic density
Trinh T, Christensen Se, Brand Js, Cuzick J, Czene K, Sjölander A, et al
British journal of cancer 2015;113(1):159-65

Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers
Li J, Holm J, Bergh J, Eriksson M, Darabi H, Lindström Ls, et al
Annals of oncology : official journal of the European Society for Medical Oncology 2015;26(3):517-22

Breast cancer tumour growth modelling for studying the association of body size with tumour growth rate and symptomatic detection using case-control data
Abrahamsson L, Czene K, Hall P, Humphreys K
Breast cancer research : BCR 2015;17():116-

Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk
Genica Network, Aocs, Rendocas, Anecs, Nsecg, Carvajal-carmona Lg, et al
HUMAN GENETICS 2015;134(2):231-45

Childhood injury after a parental cancer diagnosis
Chen R, Regodón Wallin A, Sjölander A, Valdimarsdóttir U, Ye W, Tiemeier H, et al
eLife 2015;4():-

Common germline polymorphisms associated with breast cancer-specific survival
Nbcs Investigators, Kconfab Investigators, Pirie A, Guo Q, Kraft P, Canisius S, et al
Breast cancer research : BCR 2015;17():58-

Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer
Aocs Group, Australian National Endometrial Cancer Study Group (anecs), Rendocas, National Study Of Endometrial Cancer Genetics Group (nsecg), O'mara Ta, Glubb Dm, et al
Endocrine-related cancer 2015;22(5):851-61

Distinct effects of anti-inflammatory and anti-thrombotic drugs on cancer characteristics at diagnosis
Pawitan Y, Yin L, Setiawan A, Auer G, Smedby Ke, Czene K
European journal of cancer (Oxford, England : 1990) 2015;51(6):751-7

Effectiveness of population-based service screening with mammography for women ages 40 to 49 years with a high or low risk of breast cancer: socioeconomic status, parity, and age at birth of first child
Hellquist Bn, Czene K, Hjälm A, Nyström L, Jonsson H
Cancer 2015;121(2):251-8

Exome sequencing of contralateral breast cancer identifies metastatic disease
Klevebring D, Lindberg J, Rockberg J, Hilliges C, Hall P, Sandberg M, et al
Breast cancer research and treatment 2015;151(2):319-24

Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2
Kconfab Investigators, Genica Network, Australian Ovarian Cancer Study Group, Orr N, Dudbridge F, Dryden N, et al
Human molecular genetics 2015;24(10):2966-84

Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk
Australian Ovarian Cancer Study (aocs), Rendocas, National Study Of Endometrial Cancer Genetics Group (nsecg), Chibcha Consortium, Genica Network, Australian National Endometrial Cancer Study Group (anecs), et al
Human molecular genetics 2015;24(5):1478-92

Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk
Kconfab Investigators, Guo X, Long J, Zeng C, Michailidou K, Ghoussaini M, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015;24(11):1680-91

Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1
Norwegian Breast Cancer Study, Kconfab Investigators, Genica Network, Glubb Dm, Maranian Mj, Michailidou K, et al
American journal of human genetics 2015;96(1):5-20

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
Bocs, Nbcs, Kconfab Investigators, Aocs Group, Genica Network, Michailidou K, et al
Nature genetics 2015;47(4):373-80

Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization
Drive Project, Kconfab Investigators Australian Ovarian Study Group, Zhang B, Shu Xo, Delahanty Rj, Zeng C, et al
Journal of the National Cancer Institute 2015;107(11):-

Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk
Genica Network, Breast And Ovarian Cancer Susceptibility (bocs) Study, Australian Ovarian Cancer Study Group, Kconfab Investigators, Lin Wy, Camp Nj, et al
Human molecular genetics 2015;24(1):285-98

Identification of novel genetic markers of breast cancer survival
Kconfab Investigators, Guo Q, Schmidt Mk, Kraft P, Canisius S, Chen C, et al
Journal of the National Cancer Institute 2015;107(5):-

Identification of two novel mammographic density loci at 6Q25.1
Brand Js, Li J, Humphreys K, Karlsson R, Eriksson M, Ivansson E, et al
Breast cancer research : BCR 2015;17():75-

Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer
Kconfab Investigators, Genica Network, Australian Ovarian Cancer Study Group, Kabisch M, Lorenzo Bermejo J, Dünnebier T, et al
Carcinogenesis 2015;36(2):256-71

Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors
Genica-network, Aocs Grp, Kconfab Investigators, Rudolph A, Milne Rl, Truong T, et al
INTERNATIONAL JOURNAL OF CANCER 2015;136(6):E685-96

Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair
Kconfab Investigators, Practical Consortium, Lifelines Cohort Study, Epic-interact Consortium, Generation Scotland, Aocs Investigators, et al
Nature genetics 2015;47(11):1294-1303

Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1
Cheng Th, Thompson D, Painter J, O'mara T, Gorman M, Martin L, et al
Scientific reports 2015;5():17369-

Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures
Stone J, Thompson Dj, Dos Santos Silva I, Scott C, Tamimi Rm, Lindstrom S, et al
Cancer research 2015;75(12):2457-67

Parental cancer diagnosis and child mortality--a population-based cohort study in Sweden
Chen R, Sjölander A, Valdimarsdóttir U, Varnum C, Almqvist C, Ye W, et al
Cancer epidemiology 2015;39(1):79-85

Patterns of changing cancer risks with time since diagnosis of a sibling
Lee M, Czene K, Rebora P, Reilly M
International journal of cancer 2015;136(8):1948-56

Pectoral muscle attenuation as a marker for breast cancer risk in full-field digital mammography
Cheddad A, Czene K, Hall P, Humphreys K
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015;24(6):985-91

Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression
German Consortium Of Hereditary Breast And Ovarian Cancer, Kconfab/aocs Investigators, Darabi H, Mccue K, Beesley J, Michailidou K, et al
American journal of human genetics 2015;97(1):22-34

Prediction of breast cancer risk based on profiling with common genetic variants
Mavaddat N, Pharoah Pd, Michailidou K, Tyrer J, Brook Mn, Bolla Mk, et al
Journal of the National Cancer Institute 2015;107(5):-

Predictors of Discontinuation of Adjuvant Hormone Therapy in Patients With Breast Cancer
He W, Fang F, Varnum C, Eriksson M, Hall P, Czene K
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015;33(20):2262-9

Risk factors and tumor characteristics of interval cancers by mammographic density
Holm J, Humphreys K, Li J, Ploner A, Cheddad A, Eriksson M, et al
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015;33(9):1030-7

Risk of Sex-Specific Cancers in Opposite-Sex and Same-Sex Twins in Denmark and Sweden
Ahrenfeldt Lj, Skytthe A, Möller S, Czene K, Adami Ho, Mucci La, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015;24(10):1622-8

SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival
Kconfab Investigators, Jamshidi M, Fagerholm R, Khan S, Aittomäki K, Czene K, et al
Oncotarget 2015;6(35):37979-94

The impact of co-morbidity on health-related quality of life in breast cancer survivors and controls
Schoormans D, Czene K, Hall P, Brandberg Y
Acta oncologica (Stockholm, Sweden) 2015;54(5):727-34

The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients
Kconfab Investigators, Fagerholm R, Schmidt Mk, Khan S, Rafiq S, Tapper W, et al
Oncotarget 2015;6(10):7390-407

2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy
Kconfab Investigators, Li J, Lindström Ls, Foo Jn, Rafiq S, Schmidt Mk, et al
Nature communications 2014;5():4051-

A Genome-wide Association Study of Early-Onset Breast Cancer Identifies PFKM as a Novel Breast Cancer Gene and Supports a Common Genetic Spectrum for Breast Cancer at Any Age
Familial Breast Canc Study, Ahsan H, Halpern J, Kibriya Mg, Pierce Bl, Tong L, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2014;23(4):658-69

A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46 450 cases and 42 461 controls from the breast cancer association consortium
Tnbcc, Genica Network, Australian Ovarian Canc Study Grp, Kcon Fab Investigators, Milne Rl, Herranz J, et al
HUMAN MOLECULAR GENETICS 2014;23(7):1934-46

Area and volumetric density estimation in processed full-field digital mammograms for risk assessment of breast cancer
Cheddad A, Czene K, Eriksson M, Li J, Easton D, Hall P, et al
PloS one 2014;9(10):e110690-

Automated measurement of volumetric mammographic density: a tool for widespread breast cancer risk assessment
Brand Js, Czene K, Shepherd Ja, Leifland K, Heddson B, Sundbom A, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2014;23(9):1764-72

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
Australian Ovarian Cancer Study Group, Genica Network, Kconfab Investigators, Tnbcc, Milne Rl, Burwinkel B, et al
Human molecular genetics 2014;23(22):6096-111

Comparison of fully and semi-automated area-based methods for measuring mammographic density and predicting breast cancer risk
Sovio U, Li J, Aitken Z, Humphreys K, Czene K, Moss S, et al
British journal of cancer 2014;110(7):1908-16

CYP2B6(star)6 is associated with increased breast cancer risk
Justenhoven C, Pentimalli D, Rabstein S, Harth V, Lotz A, Pesch B, et al
INTERNATIONAL JOURNAL OF CANCER 2014;134(2):426-30

DNA mismatch repair gene MSH6 implicated in determining age at natural menopause
Reprogen Consortium, Kconfab Investigators, Perry Jrb, Hsu Yh, Chasman Di, Johnson Ad, et al
HUMAN MOLECULAR GENETICS 2014;23(9):2490-7

Enhancement of mammographic density measures in breast cancer risk prediction
Cheddad A, Czene K, Shepherd Ja, Li J, Hall P, Humphreys K
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2014;23(7):1314-23

Evaluation of exome sequencing to estimate tumor burden in plasma
Klevebring D, Neiman M, Sundling S, Eriksson L, Darai Ramqvist E, Celebioglu F, et al
PloS one 2014;9(8):e104417-

Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation
Australian Ovarian Cancer Management Group, Australian Ovarian Cancer Management Group, Ghoussaini M, Edwards Sl, Michailidou K, Nord S, et al
Nature communications 2014;4():4999-

FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium
Tnbcc, Genica Network, Australian Ovarian Cancer Study Gr, Kconfab Investigators, Agarwal D, Pineda S, et al
BRITISH JOURNAL OF CANCER 2014;110(4):1088-100

Genetic predisposition to in situ and invasive lobular carcinoma of the breast
Genica Network, Sawyer E, Roylance R, Petridis C, Brook Mn, Nowinski S, et al
PLoS genetics 2014;10(4):e1004285-

Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade
Kconfab Investigators, Genica Network, Abctb Investigators, Australian Ovarian Cancer Study Group, Purrington Ks, Slettedahl S, et al
Human molecular genetics 2014;23(22):6034-46

Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk
Lindström S, Thompson Dj, Paterson Ad, Li J, Gierach Gl, Scott C, et al
Nature communications 2014;5():5303-

Identification of New Genetic Susceptibility Loci for Breast Cancer Through Consideration of Gene-Environment Interactions
Schoeps A, Rudolph A, Seibold P, Dunning Am, Milne Rl, Bojesen Se, et al
GENETIC EPIDEMIOLOGY 2014;38(1):84-93

MicroRNA related polymorphisms and breast cancer risk
Genica Network, Australian Ovarian Cancer Study Group, Kconfab Investigators, Khan S, Greco D, Michailidou K, et al
PloS one 2014;9(11):e109973-

Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche
Early Growth Genetics (egg) Consortium, Australian Ovarian Cancer Study, Genica Network, Kconfab, Lifelines Cohort Study, Interact Consortium, et al
Nature 2014;514(7520):92-97

Pregnancy during breast cancer: does a mother's parity status modify an offspring's mortality risk?
Simonella L, Verkooijen Hm, Edgren G, Liu Jn, Hui M, Salim A, et al
BREAST CANCER RESEARCH AND TREATMENT 2014;146(2):393-9

Prognostic information of a previously diagnosed sister is an independent prognosticator for a newly diagnosed sister with breast cancer
Lindström Ls, Li J, Lee M, Einbeigi Z, Hartman M, Hall P, et al
Annals of oncology : official journal of the European Society for Medical Oncology 2014;25(10):1966-72

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia
Kconfab Investigators, Hebon Group, Genica Network, Embrace Group, Abctb Investigators, Spurdle Ab, et al
BREAST CANCER RESEARCH 2014;16(6):3419-

Sequencing of breast cancer stem cell populations indicates a dynamic conversion between differentiation states in vivo
Klevebring D, Rosin G, Ma R, Lindberg J, Czene K, Kere J, et al
BREAST CANCER RESEARCH 2014;16(4):R72-

The heritability of prostate cancer in the Nordic Twin Study of Cancer
Hjelmborg Jb, Scheike T, Holst K, Skytthe A, Penney Kl, Graff Re, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2014;23(11):2303-10

Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics
Colzani E, Johansson Al, Liljegren A, Foukakis T, Clements M, Adolfsson J, et al
British journal of cancer 2014;110(5):1378-84

Volumetric mammographic density: heritability and association with breast cancer susceptibility loci
Brand Js, Humphreys K, Thompson Dj, Li J, Eriksson M, Hall P, et al
Journal of the National Cancer Institute 2014;106(12):-

A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication
Genica Network, Hein R, Flesch-janys D, Dahmen N, Beckmann L, Lindstrom S, et al
BREAST CANCER RESEARCH AND TREATMENT 2013;138(2):529-542

Association of CYP2D6 metabolizer status with mammographic density change in response to tamoxifen treatment
Li Jm, Czene K, Brauch H, Schroth W, Saladores P, Li Y, et al
BREAST CANCER RESEARCH 2013;15(5):R93-

A unified model for estimating and testing familial aggregation
Lee M, Rebora P, Valsecchi Mg, Czene K, Reilly M
Statistics in medicine 2013;32(30):5353-65

Birth rates among female cancer survivors: a population-based cohort study in Sweden
Hartman M, Liu J, Czene K, Miao H, Chia Ks, Salim A, et al
Cancer 2013;119(10):1892-9

Change of mammographic density predicts the risk of contralateral breast cancer - a case-control study
Sandberg Mec, Li Jm, Hall P, Hartman M, Dos-santos-silva I, Humphreys K, et al
BREAST CANCER RESEARCH 2013;15(4):R57-

Fine-Scale Mapping of the FGFR2 Breast Cancer Risk Locus: Putative Functional Variants Differentially Bind FOXA1 and E2F1
Group Aocs, Investigators K, Network G, Meyer Kb, O'reilly M, Michailidou K, et al
AMERICAN JOURNAL OF HUMAN GENETICS 2013;93(6):1046-60

Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers
Genica Network, Kconfab Investigators, French Jd, Ghoussaini M, Edwards Sl, Meyer Kb, et al
AMERICAN JOURNAL OF HUMAN GENETICS 2013;92(4):489-503

Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study
Breast Canc Association Consortium, Aocs Management Grp, Kconfab Investigators, Genica Network, Rudolph A, Hein R, et al
ENDOCRINE-RELATED CANCER 2013;20(6):875-87

Genome-wide association studies identify four ER negative-specific breast cancer risk loci
Familial Breast Canc Study Fbcs, Gene Environm Interaction Breast, Kconfab Investigators, Australian Breast Canc Tissue Bank, Garcia-closas M, Couch Fj, et al
NATURE GENETICS 2013;45(4):392-8

Influence of lifestyle factors on mammographic density in postmenopausal women
Brand Js, Czene K, Eriksson L, Trinh T, Bhoo-pathy N, Hall P, et al
PloS one 2013;8(12):e81876-

Influence of radiotherapy for the first tumor on aggressiveness of contralateral breast cancer
Sandberg Me, Alkner S, Hartman M, Eloranta S, Rydén L, Ploner A, et al
International journal of cancer 2013;132(10):2388-94

Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Genica Gene Environm Interaction B, Australian Ovarian Can Study Grp, Kconfab Investigators, Hereditary Breast Ovarian Canc Res, Breast Ovarian Canc Susceptibility, Michailidou K, et al
NATURE GENETICS 2013;45(4):353-61

Large-scale genotyping identifies a new locus at 22q13.2 associated with female breast size
Li Jm, Foo Jn, Schoof N, Varghese Js, Fernandez-navarro P, Gierach Gl, et al
JOURNAL OF MEDICAL GENETICS 2013;50(10):666-73

Low-dose aspirin use and cancer characteristics: a population-based cohort study
Jonsson F, Yin L, Lundholm C, Smedby Ke, Czene K, Pawitan Y
British journal of cancer 2013;109(7):1921-5

Mammographic density and survival in interval breast cancers
Eriksson L, Czene K, Rosenberg Lu, Tornberg S, Humphreys K, Hall P
BREAST CANCER RESEARCH 2013;15(3):R48-

Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer
Li J, Humphreys K, Eriksson L, Edgren G, Czene K, Hall P
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(18):2249-56

Mortality among offspring of women diagnosed with cancer: A population-based cohort study
Verkooijen Hm, Ang Jx, Liu J, Czene K, Salim A, Hartman M
INTERNATIONAL JOURNAL OF CANCER 2013;132(10):2432-8

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Genetic Modifiers Canc Risk Brca1, Epidemiological Study Brca1, Hereditary Breast Ovarian Canc Res, Swedish Breast Canc Study Swe-brca, Gene Environm Interactimi Breast, Kathleen Cuningham Fdn Consortium, et al
NATURE GENETICS 2013;45(4):371-84

Possible influence of mammographic density on local and locoregional recurrence of breast cancer
Eriksson L, Czene K, Rosenberg L, Humphreys K, Hall P
BREAST CANCER RESEARCH 2013;15(4):R56-

11q13 is a susceptibility locus for hormone receptor positive breast cancer
Australian Ovarian Canc Study Grp, Kconfab Investigators, Genica Network, Lambrechts D, Truong T, Justenhoven C, et al
HUMAN MUTATION 2012;33(7):1123-32

19p13.1 Is a Triple-Negative-Specific Breast Cancer Susceptibility Locus
Aocs Grp, Kconfab Investigators, Genica Network, Stevens Kn, Fredericksen Z, Vachon Cm, et al
CANCER RESEARCH 2012;72(7):1795-803

9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
Australian Ovarian Canc Study Grp, Kconfab Investigators, Genica Network, Warren H, Dudbridge F, Fletcher O, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2012;21(10):1783-91

A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11
Genica Consortium, Familial Breast Canc Study, Australian Breast Canc Tissue Bank, Siddiq A, Couch Fj, Chen Gk, et al
HUMAN MOLECULAR GENETICS 2012;21(24):5373-84

Breast cancer prognosis is inherited independently of patient, tumor and treatment characteristics
Verkooijen Hm, Hartman M, Usel M, Benhamou S, Neyroud-caspar I, Czene K, et al
INTERNATIONAL JOURNAL OF CANCER 2012;130(9):2103-10

Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement
Darabi H, Czene K, Zhao W, Liu J, Hall P, Humphreys K
Breast cancer research : BCR 2012;14(1):R25-

CHEK2*1100delC Heterozygosity in Women With Breast Cancer Associated With Early Death, Breast Cancer-Specific Death, and Increased Risk of a Second Breast Cancer
Weischer M, Nordestgaard Bg, Pharoah P, Bolla Mk, Nevanlinna H, Van't Veer Lj, et al
JOURNAL OF CLINICAL ONCOLOGY 2012;30(35):4308-16

Common Breast Cancer Susceptibility Variants in LSP1 and RAD51L1 Are Associated with Mammographic Density Measures that Predict Breast Cancer Risk
Vachon Cm, Scott Cg, Fasching Pa, Hall P, Tamimi Rm, Li Jm, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2012;21(7):1156-66

Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Aocs Grp, Genica Network, Kconfab Investigators, Hein R, Maranian M, Hopper Jl, et al
PLOS ONE 2012;7(8):e42380-

Estrogen receptor status in relation to risk of contralateral breast cancer-a population-based cohort study
Sandberg Me, Hall P, Hartman M, Johansson Al, Eloranta S, Ploner A, et al
PloS one 2012;7(10):e46535-

Genetic Variants in ER Cofactor Genes and Endometrial Cancer Risk
Anecs Grp, Li Yq, Low Hq, Foo Jn, Darabi H, Einarsdottir K, et al
PLOS ONE 2012;7(8):e42445-

Genome-wide association analysis identifies three new breast cancer susceptibility loci
Australian Ovarian Canc Study Grp, Kconfab Investigators, Gene Environm Interaction Breast C, Fbcs, Netherlands Collaborative Grp Here, Ghoussaini M, et al
NATURE GENETICS 2012;44(3):312-8

High-throughput mammographic-density measurement: a tool for risk prediction of breast cancer
Li Jm, Szekely L, Eriksson L, Heddson B, Sundbom A, Czene K, et al
BREAST CANCER RESEARCH 2012;14(4):R114-

Identification of a novel percent mammographic density locus at 12q24
Stevens Kn, Lindstrom S, Scott Cg, Thompson D, Sellers Ta, Wang Xs, et al
HUMAN MOLECULAR GENETICS 2012;21(14):3299-305

Library preparation and multiplex capture for massive parallel sequencing applications made efficient and easy
Neiman M, Sundling S, Grönberg H, Hall P, Czene K, Lindberg J, et al
PloS one 2012;7(11):e48616-

Mammographic Breast Density and Breast Cancer: Evidence of a Shared Genetic Basis
Mode Consortium, Varghese Js, Thompson Dj, Michailidou K, Lindstrom S, Turnbull C, et al
CANCER RESEARCH 2012;72(6):1478-84

Mammographic density and molecular subtypes of breast cancer
Eriksson L, Hall P, Czene K, Dos Santos Silva I, Mccormack V, Bergh J, et al
British journal of cancer 2012;107(1):18-23

No evidence for association of inherited variation in genes involved in mitosis and percent mammographic density
Vachon Cm, Li Jm, Scott Cg, Hall P, Czene K, Wang Xs, et al
BREAST CANCER RESEARCH 2012;14(1):R7-

Partitioning of excess mortality in population-based cancer patient survival studies using flexible parametric survival models
Eloranta S, Lambert Pc, Andersson Tm, Czene K, Hall P, Björkholm M, et al
BMC medical research methodology 2012;12():86-

Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer
Sandberg Me, Hartman M, Klevebring D, Eloranta S, Ploner A, Hall P, et al
Breast cancer research and treatment 2012;134(2):793-800

The influence of mammographic density on breast tumor characteristics
Eriksson L, Czene K, Rosenberg L, Humphreys K, Hall P
Breast cancer research and treatment 2012;134(2):859-66

The role of genetic breast cancer susceptibility variants as prognostic factors
Kconfab Investigators, Fasching Pa, Pharoah Pdp, Cox A, Nevanlinna H, Bojesen Se, et al
HUMAN MOLECULAR GENETICS 2012;21(17):3926-39

7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium
Aocs Grp, Kconfab Investigators, Genica Network, Milne Rl, Lorenzo-bermejo J, Burwinkel B, et al
JOURNAL OF MEDICAL GENETICS 2011;48(10):698-702

A combined analysis of genome-wide association studies in breast cancer
Li Jm, Humphreys K, Heikkinen T, Aittomaki K, Blomqvist C, Pharoah Pdp, et al
BREAST CANCER RESEARCH AND TREATMENT 2011;126(3):717-27

Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
Yang Xr, Chang-claude J, Goode El, Couch Fj, Nevanlinna H, Milne Rl, et al
JOURNAL OF THE NATIONAL CANCER INSTITUTE 2011;103(3):250-63

Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium
Kconfab Aocs Management Grp, Genica Network, Figueroa Jd, Garcia-closas M, Humphreys M, Platte R, et al
HUMAN MOLECULAR GENETICS 2011;20(23):4693-706

Coffee consumption modifies risk of estrogen-receptor negative breast cancer
Li Jm, Seibold P, Chang-claude J, Flesch-janys D, Liu Jj, Czene K, et al
BREAST CANCER RESEARCH 2011;13(3):R49-

Common variants in ZNF365 are associated with both mammographic density and breast cancer risk
Lindstrom S, Vachon Cm, Li Jm, Varghese J, Thompson D, Warren R, et al
NATURE GENETICS 2011;43(3):185-7

Genetic variation in the androgen estrogen conversion pathway in relation to breast cancer prognosticators
Darabi H, Czene K, Wedren S, Li Yq, Liu Jj, Hall P, et al
BREAST CANCER RESEARCH AND TREATMENT 2011;127(2):503-9

Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer
Li Yq, Li Y, Wedren S, Li Gl, Charn Th, Desai Kv, et al
BREAST CANCER RESEARCH 2011;13(1):R10-

Genome-wide association study identifies a common variant associated with risk of endometrial cancer
Natl Study Endometrial Canc Geneti, Australian Natl Endometrial Canc, Spurdle Ab, Thompson Dj, Ahmed S, Ferguson K, et al
NATURE GENETICS 2011;43(5):451-4

Incidence and Outcome of Male Breast Cancer: An International Population-Based Study
Miao H, Verkooijen Hm, Chia Ks, Bouchardy C, Pukkala E, Laronningen S, et al
JOURNAL OF CLINICAL ONCOLOGY 2011;29(33):4381-6

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium
Aocs, Kconfab, Genica Network, Broeks A, Schmidt Mk, Sherman Me, et al
HUMAN MOLECULAR GENETICS 2011;20(16):3289-303

Progesterone receptor gene variants and risk of endometrial cancer
Anecs, Search, Aocs Management Grp, Wise Study Grp, Sasbac, O'mara Ta, et al
CARCINOGENESIS 2011;32(3):331-5

Prognosis of Patients With Breast Cancer: Causes of Death and Effects of Time Since Diagnosis, Age, and Tumor Characteristics
Colzani E, Liljegren A, Johansson Alv, Adolfsson J, Hellborg H, Hall Pfl, et al
JOURNAL OF CLINICAL ONCOLOGY 2011;29(30):4014-21

Swedish Population Substructure Revealed by Genome-Wide Single Nucleotide Polymorphism Data
Salmela E, Lappalainen T, Liu Jj, Sistonen P, Andersen Pm, Schreiber S, et al
PLOS ONE 2011;6(2):e16747-

The role of mammography screening attendance and detection mode in predicting breast cancer survival-Is there added prognostic value?
Biesheuvel C, Czene K, Orgeas Cc, Hall P
CANCER EPIDEMIOLOGY 2011;35(6):545-50

A genome-wide association scan on estrogen receptor-negative breast cancer
Li Jm, Humphreys K, Darabi H, Rosin G, Hannelius U, Heikkinen T, et al
BREAST CANCER RESEARCH 2010;12(6):R93-

Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study
Aocs, Kconfab, Genica Network, Milne Rl, Gaudet Mm, Spurdle Ab, et al
BREAST CANCER RESEARCH 2010;12(6):R110-

Association Between a Germline OCA2 Polymorphism at Chromosome 15q13.1 and Estrogen Receptor-Negative Breast Cancer Survival
Kathleen Cuningham Fdn Consortium, Azzato Em, Tyrer J, Fasching Pa, Beckmann Mw, Ekici Ab, et al
JOURNAL OF THE NATIONAL CANCER INSTITUTE 2010;102(9):650-62

Bias correction of estimates of familial risk from population-based cohort studies
Leu M, Czene K, Reilly M
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY 2010;39(1):80-8

Birth weight and mammographic density among postmenopausal women in Sweden
Tamimi Rm, Eriksson L, Lagiou P, Czene K, Ekbom A, Hsieh Cc, et al
INTERNATIONAL JOURNAL OF CANCER 2010;126(4):985-91

Birth weight, breast cancer susceptibility loci, and breast cancer risk
Tamimi Rm, Lagiou P, Czene K, Liu Jj, Ekbom A, Hsieh Cc, et al
CANCER CAUSES & CONTROL 2010;21(5):689-96

Diagnostic work-up of contralateral breast cancers has not improved over calendar period
Sandberg Mec, Hartman M, Edgren G, Eloranta S, Ploner A, Hall P, et al
BREAST CANCER RESEARCH AND TREATMENT 2010;122(3):889-95

Effect of childbirth after treatment on long-term survival from breast cancer
Verkooijen Hm, Lim Gh, Czene K, Bhalla V, Chow Ky, Yap Kpl, et al
BRITISH JOURNAL OF SURGERY 2010;97(8):1253-9

Effects of childhood body size on breast cancer tumour characteristics
Li Jm, Humphreys K, Eriksson L, Czene K, Liu Jj, Hall P
BREAST CANCER RESEARCH 2010;12(2):R23-

Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer
Li Jm, Eriksson L, Humphreys K, Czene K, Liu Jj, Tamimi Rm, et al
BREAST CANCER RESEARCH 2010;12(2):R19-

Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 Controls
Breast Canc Assoc Consortium, Genica Consortium, Aocs Grp, Kconfab Investigators, Fletcher O, Johnson N, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2010;19(9):2143-51

Multi-Variant Pathway Association Analysis Reveals the Importance of Genetic Determinants of Estrogen Metabolism in Breast and Endometrial Cancer Susceptibility
Low Yl, Li Yq, Humphreys K, Thalamuthu A, Li Y, Darabi H, et al
PLOS GENETICS 2010;6(7):e1001012-

Pathological confirmation of primary lung cancer following breast cancer
Tennis M, Singh B, Hjerpe A, Prochazka M, Czene K, Hall P, et al
LUNG CANCER 2010;69(1):40-5

A constant risk for familial breast cancer? A population-based family study
Czene K, Reilly M, Hall P, Hartman M
BREAST CANCER RESEARCH 2009;11(3):R30-

Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study
Orgeas Cc, Sanner K, Hall P, Conner P, Holte J, Nilsson Sj, et al
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 2009;200(1):72.e1-7

Common genetic variability in ESR1 and EGF in relation to endometrial cancer risk and survival
Einarsdottir K, Darabi H, Czene K, Li Y, Low Yl, Li Yq, et al
BRITISH JOURNAL OF CANCER 2009;100(8):1358-64

Do Asian breast cancer patients have poorer survival than their western counterparts? A comparison between Singapore and Stockholm
Tan Bkt, Lim Gh, Czene K, Hall P, Chia Ks
BREAST CANCER RESEARCH 2009;11(1):R4-

Five Polymorphisms and Breast Cancer Risk: Results from the Breast Cancer Association Consortium
Australian Ovarian Canc Study Grp, Breast Canc Assoc Consortium, Georgia Chenevix-trench, Gaudet Mm, Milne Rl, Cox A, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2009;18(5):1610-6

Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer development
Genica Consortium, Australian Ovarian Cancer Study Group, Kathleen Cuningham Foundation Consortium For Research Into Familial Breast Cancer, Liu J, Desai Kv, Li Y, et al
The HUGO journal 2009;3(1-4):31-40

How the Effect of Maternal Age on the Risk of Childhood Leukemia Changed over Time in Sweden, 1960-2004
Maule Mm, Vizzini L, Czene K, Akre O, Richiardi L
ENVIRONMENTAL HEALTH PERSPECTIVES 2009;117(2):299-302

Is Genetic Background Important in Lung Cancer Survival?
Lindstrom Ls, Hall P, Hartman M, Wiklund F, Czene K
PLOS ONE 2009;4(5):e5588-

Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2
Australian Ovarian Cancer Study, Kconfab, Genica Consortium, Search, Ahmed S, Thomas G, et al
NATURE GENETICS 2009;41(5):585-90

No evidence that GATA3 rs570613 SNP modifies breast cancer risk
Breast Canc Assoc Consortium, Swedish Brca1, Brca2 Study Collaborators, Hebon, Consortium Investigators Modifiers, Kconfab Investigators, et al
BREAST CANCER RESEARCH AND TREATMENT 2009;117(2):371-9

Obesity and poor breast cancer prognosis: an illusion because of hormone replacement therapy?
Rosenberg L, Czene K, Hall P
BRITISH JOURNAL OF CANCER 2009;100(9):1486-91

Risk of Estrogen Receptor-Positive and -Negative Breast Cancer and Single-Nucleotide Polymorphism 2q35-rs13387042
Breast Canc Assoc Consortium, Aocs Grp, Kconfab Investigators, Milne Rl, Benitez J, Nevanlinna H, et al
JOURNAL OF THE NATIONAL CANCER INSTITUTE 2009;101(14):1012-8

The influence of menopausal hormone therapy on tumour characteristics and survival in endometrial cancer patients
Orgeas Cc, Hall P, Wedren S, Dickman Pw, Czene K
EUROPEAN JOURNAL OF CANCER 2009;45(17):3064-73

Breast cancer onset in twins and women with bilateral disease
Hartman M, Hall P, Edgren G, Reilly M, Lindstrom L, Lichtenstein P, et al
JOURNAL OF CLINICAL ONCOLOGY 2008;26(25):4086-91

ESR1 and EGF genetic variation in relation to breast cancer risk and survival
Einarsdottir K, Darabi H, Li Y, Low Yl, Li Yq, Bonnard C, et al
BREAST CANCER RESEARCH 2008;10(1):R15-

Evaluation of bias in familial risk estimates: A study of common cancers using Swedish population-based registers
Leu M, Reilly M, Czene K
JOURNAL OF THE NATIONAL CANCER INSTITUTE 2008;100(18):1318-25

Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics
Australian Ovarian, Kathleen Cuningham Fdn Consortium, Garcia-closas M, Hall P, Nevanlinna H, Pooley K, et al
PLOS GENETICS 2008;4(4):e1000054-

The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer
Orgeas Cc, Hall P, Rosenberg Lu, Czene K
BREAST CANCER RESEARCH 2008;10(6):R107-

Timing of familial breast cancer in sisters
Rebora P, Czene K, Reilly M
JOURNAL OF THE NATIONAL CANCER INSTITUTE 2008;100(10):721-7

Validation of smoking history in cancer patients
Prochazka M, Hall P, Granath F, Czene K
ACTA ONCOLOGICA 2008;47(6):1004-8

Etiology of familial aggregation in melanoma and squamous cell carcinoma of the skin
Lindstrom Ls, Yip B, Lichtenstein P, Pawitan Y, Czene K
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2007;16(8):1639-43

Familial concordance in cancer survival: a Swedish population-based study
Lindstrom Ls, Hall P, Hartman M, Wiklund F, Gronberg H, Czene K
LANCET ONCOLOGY 2007;8(11):1001-6

Incidence and prognosis of synchronous and Metachronous bilateral breast cancer
Hartman M, Czene K, Reilly M, Adolfsson J, Bergh J, Adami Ho, et al
JOURNAL OF CLINICAL ONCOLOGY 2007;25(27):4210-6

Is breast cancer prognosis inherited?
Hartman M, Lindstom L, Dickman Pw, Adami Ho, Hall P, Czene K
BREAST CANCER RESEARCH 2007;9(3):R39-

"Population lab" - The creation of virtual populations for genetic epidemiology research
Leu M, Czene K, Reilly M
EPIDEMIOLOGY 2007;18(4):433-40

Sex- and kindred-specific familial risk of non-Hodgkin's lymphoma
Czene K, Adami Ho, Chang Et
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2007;16(11):2496-9

The impact of truncation and missing family links in population-based registers on familial risk estimates
Leu M, Czene K, Reilly M
AMERICAN JOURNAL OF EPIDEMIOLOGY 2007;166(12):1461-7

Estimation of genetic and environmental factors for melanoma onset using population-based family data
Lindstrom L, Pawitan Y, Reilly M, Hemminki K, Lichtenstein P, Czene K
STATISTICS IN MEDICINE 2006;25(18):3110-23

Family history of breast cancer and young age at diagnosis of breast cancer increase risk of second primary malignancies in women: a population-based cohort study
Prochazka M, Hall P, Granath F, Czene K
BRITISH JOURNAL OF CANCER 2006;95(9):1291-5

Parental age and risk of childhood cancers: a population-based cohort study from Sweden
Yip Bh, Pawitan Y, Czene K
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY 2006;35(6):1495-503

Genetic implications of bilateral breast cancer: A population-based cohort study
Hartman M, Czene K, Reilly M, Bergh J, Lagiou P, Trichopoulos D, et al
LANCET ONCOLOGY 2005;6(6):377-82

Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer: Case-only design
Prochazka M, Hall P, Gagliardi G, Granath F, Nilsson Bn, Shields Pg, et al
JOURNAL OF CLINICAL ONCOLOGY 2005;23(30):7467-74

Familial risk of cancer: Data for clinical counseling and cancer genetics
Hemminki K, Li Xj, Czene K
INTERNATIONAL JOURNAL OF CANCER 2004;108(1):109-14

Familial risk of urological cancers: data for clinical counseling
Hemminki K, Li Xj, Czene K
WORLD JOURNAL OF UROLOGY 2004;21(6):377-81

BRAF mutations in metastatic melanoma: A possible association with clinical outcome
Kumar R, Angelini S, Czene K, Sauroja I, Hahka-kemppinen M, Pyrhonen S, et al
CLINICAL CANCER RESEARCH 2003;9(9):3362-8

Cancer risks in hairdressers: Assessment of carcinogenicity of hair dyes and gels
Czene K, Tiikkaja S, Hemminki K
INTERNATIONAL JOURNAL OF CANCER 2003;105(1):108-12

Dosimetry by means of DNA and hemoglobin adducts in propylene oxide-exposed rats
Osterman-golkar S, Czene K, Lee Ms, Faller Th, Csanady Ga, Kessler W, et al
TOXICOLOGY AND APPLIED PHARMACOLOGY 2003;191(3):245-54

Familial and attributable risks in cutaneous melanoma: Effects of proband and age
Hemminki K, Zhang H, Czene K
JOURNAL OF INVESTIGATIVE DERMATOLOGY 2003;120(2):217-23

Familial invasive and in situ squamous cell carcinoma of the skin
Hemminki K, Zhang H, Czene K
BRITISH JOURNAL OF CANCER 2003;88(9):1375-80

Familial papillary renal cell tumors and subsequent cancers: A nationwide epidemiological study from Sweden
Czene K, Hemminki K
JOURNAL OF UROLOGY 2003;169(4):1271-5

Incidence trends and familial risks in invasive and in situ cutaneous melanoma by sun-exposed body sites
Hemminki K, Zhang H, Czene K
INTERNATIONAL JOURNAL OF CANCER 2003;104(6):764-71

Mutagenic activity of ethylene oxide and propylene oxide under XPG proficient and deficient conditions in relation to N-7-(2-hydroxyalkyl) guanine levels in Drosophila
Nivard Mjm, Czene K, Segerback D, Vogel Ew
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS 2003;529(1-2):95-107

Socioeconomic factors in cancer in Sweden
Hemminki K, Zhang H, Czene K
INTERNATIONAL JOURNAL OF CANCER 2003;105(5):692-700

Time trends and familial risks in squamous cell carcinoma of the skin
Hemminki K, Zhang H, Czene K
ARCHIVES OF DERMATOLOGY 2003;139(7):885-9

Age specific and attributable risks of familial prostate carcinoma from the family-cancer database
Hemminki K, Czene K
CANCER 2002;95(6):1346-53

Analysis of DNA and hemoglobin adducts and sister chromatid exchanges in a human population occupationally exposed to propylene oxide: A pilot study
Czene K, Osterman-golkar S, Yun X, Li G, Zhao Fl, Perez Hl, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2002;11(3):315-8

Attributable risks for familial breast cancer by proband status and morphology: A nationwide epidemiologic study from Sweden
Hemminki K, Granstrom C, Czene K
INTERNATIONAL JOURNAL OF CANCER 2002;100(2):214-9

Attributable risks of familial cancer from the family-cancer database
Hemminki K, Czene K
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2002;11(12):1638-44

Cancer risks in first-generation immigrants to Sweden
Hemminki K, Li Xj, Czene K
INTERNATIONAL JOURNAL OF CANCER 2002;99(2):218-28

Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family-cancer database
Czene K, Lichtenstein P, Hemminki K
INTERNATIONAL JOURNAL OF CANCER 2002;99(2):260-6

Kidney cancer in the Swedish family cancer database: Familial risks and second primary malignancics
Czene Ka, Hemminki K
KIDNEY INTERNATIONAL 2002;61(5):1806-13

Familial bladder cancer in the national Swedish family cancer database
Plna K, Hemminki K
JOURNAL OF UROLOGY 2001;166(6):2129-33

The nation-wide Swedish Family-Cancer Database - Updated structure and familial rates
Hemminki K, Li Xj, Plna K, Granstrom C, Vaittinen P
ACTA ONCOLOGICA 2001;40(6):772-7

P-32-post-labelling of 7-(3-chloro-2-hydroxypropyl)guanine in white blood cells of workers occupationally exposed to epichlorohydrin
Plna K, Osterman-golkar S, Nogradi E, Segerback D
CARCINOGENESIS 2000;21(2):275-80

P-32-postlabelling of propylene oxide 1-and N-6-substituted adenine and 3-substituted cytosine/uracil: formation and persistence in vitro and in vivo
Plna K, Nilsson R, Koskinen M, Segerback D
CARCINOGENESIS 1999;20(10):2025-32

Tissue distribution of DNA adducts in male Fischer rats exposed to 500 ppm of propylene oxide: quantitative analysis of 7-(2-hydroxypropyl)guanine by P-32-postlabelling
Segerback D, Plna K, Faller T, Kreuzer Pe, Hakansson K, Filser Jg, et al
CHEMICO-BIOLOGICAL INTERACTIONS 1998;115(3):229-46

Dosimetry of glycidyl ethers in mice by quantification of haemoglobin adducts
Perez Hl, Plna K, Ostermangolkar S
CHEMICO-BIOLOGICAL INTERACTIONS 1997;103(1):1-16

P-32-Postlabelling of DNA adducts formed by allyl glycidyl ether in vitro and in vivo
Pina K, Segerback D
CARCINOGENESIS 1997;18(8):1457-62

Propylene oxide: mutagenesis, carcinogenesis and molecular dose
Riosblanco Mn, Plna K, Faller T, Kessler W, Hakansson K, Kreuzer Pe, et al
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS 1997;380(1-2):179-97

7-Alkylguanine adducts of styrene oxide determined by P-32-postlabelling in DNA and human embryonal lung fibroblasts (HEL)
Vodicka P, Stetina R, Kumar R, Plna K, Hemminki K
CARCINOGENESIS 1996;17(4):801-8

Adduct formation on DNA and haemoglobin in mice intraperitoneally administered with styrene
Pauwels W, Vodiceka P, Severi M, Plna K, Veulemans H, Hemminki K
CARCINOGENESIS 1996;17(12):2673-80

DNA adduct formation by allyl glycidyl ether
Plna K, Segerback D, Schweda Ekh
CARCINOGENESIS 1996;17(7):1465-71

Show all publications

Map